Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts; Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts.
Department of Ophthalmology, The Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania.
Ophthalmology. 2020 Jun;127(6):826-834. doi: 10.1016/j.ophtha.2019.11.020. Epub 2019 Nov 28.
To estimate the incidence of medication-free remission of chronic anterior uveitis and identify predictors thereof.
Retrospective cohort study.
Patients diagnosed with anterior uveitis of longer than 3 months' duration followed up at United States tertiary uveitis care facilities.
Estimation of remission incidence and identification of associated predictors used survival analysis.
Incidence of medication-free remission. For the primary analysis, remission was defined as inactive uveitis while off treatment at all visits spanning an interval of at least 90 days or-for patients who did not return for follow-up after 90 days-remaining inactive without receiving suppressive medications at all of the last visits. Association of factors potentially predictive of medication-free remission was also studied.
Two thousand seven hundred ninety-five eyes of 1634 patients with chronic anterior uveitis were followed up over 7936 eye-years (4676 person-years). The cumulative medication-free, person-year remission incidence within 5 years was 32.7% (95% confidence interval [CI], 30.4%-35.2%). Baseline clinical factors predictive of reduced remission incidence included longer duration of uveitis at presentation (for 2 to 5 years vs. less than 6 months: adjusted hazard ratio [aHR], 0.61; 95% CI, 0.44-0.83), bilateral uveitis (aHR, 0.75; 95% CI, 0.59-0.96), prior cataract surgery (aHR, 0.70; 95% CI 0.56-0.88), and glaucoma surgery (aHR, 0.63; 95% CI, 0.45-0.90). Two time-updated characteristics were also predictive of reduced remission incidence: keratic precipitates (aHR, 0.36; 95% CI, 0.21-0.60) and synechiae (aHR, 0.62; 95% CI, 0.41-0.93). Systemic diagnosis with juvenile idiopathic arthritis and spondyloarthropathy were also associated with reduced remission incidence. Older age at presentation was associated with higher incidence of remission (for age ≥40 years vs. <40 years: aHR, 1.29; 95% CI, 1.02-1.63).
Approximately one third of patients with chronic anterior uveitis remit within 5 years. Longer duration of uveitis, younger age, bilateral uveitis, prior cataract surgery, glaucoma surgery, presence of keratic precipitates and synechiae, and systemic diagnoses of juvenile idiopathic arthritis and spondyloarthropathy predict reduced remission incidence; patients with these factors should be managed taking into account the higher probability of a longer disease course.
估计慢性前葡萄膜炎药物缓解的发生率,并确定其预测因素。
回顾性队列研究。
在美国三级葡萄膜炎治疗机构接受治疗的慢性前葡萄膜炎患者,病程超过 3 个月。
采用生存分析方法估计缓解发生率并确定相关预测因素。
药物缓解的发生率。在主要分析中,缓解定义为在所有随访期间停止治疗时无活动性葡萄膜炎,或在 90 天后未返回随访的患者,在最后一次随访时未接受任何抑制性药物治疗时仍处于无活动性葡萄膜炎状态。还研究了可能与药物缓解相关的因素。
对 1634 例慢性前葡萄膜炎患者的 2795 只眼进行了 7936 眼年(4676 人年)的随访。5 年内药物无缓解、人年缓解累积发生率为 32.7%(95%置信区间[CI],30.4%-35.2%)。基线临床特征预测缓解发生率降低的因素包括:葡萄膜炎发病时的病程较长(2-5 年 vs. <6 个月:调整后的危害比[aHR],0.61;95%CI,0.44-0.83)、双眼葡萄膜炎(aHR,0.75;95%CI,0.59-0.96)、既往白内障手术(aHR,0.70;95%CI,0.56-0.88)和青光眼手术(aHR,0.63;95%CI,0.45-0.90)。两个时间更新的特征也预测了缓解发生率的降低:角膜后沉着物(aHR,0.36;95%CI,0.21-0.60)和虹膜粘连(aHR,0.62;95%CI,0.41-0.93)。全身性幼年特发性关节炎和脊柱关节炎的诊断也与缓解发生率降低相关。发病时年龄较大与缓解发生率较高相关(年龄≥40 岁 vs. <40 岁:aHR,1.29;95%CI,1.02-1.63)。
约三分之一的慢性前葡萄膜炎患者在 5 年内缓解。葡萄膜炎病程较长、年龄较小、双眼葡萄膜炎、既往白内障手术、青光眼手术、角膜后沉着物和虹膜粘连的存在,以及幼年特发性关节炎和脊柱关节炎的全身性诊断预测缓解发生率降低;这些患者的管理应考虑到更长的病程。